Literature DB >> 33585368

Isoprostanes as Biomarker for White Matter Injury in Extremely Preterm Infants.

Caterina Coviello1, Serafina Perrone2, Giuseppe Buonocore3, Simona Negro3, Mariangela Longini3, Carlo Dani1, Linda S de Vries4, Floris Groenendaal4, Daniel C Vijlbrief4, Manon J N L Benders4, Maria Luisa Tataranno4.   

Abstract

Background and Aim: Preterm white matter is vulnerable to lipid peroxidation-mediated injury. F2-isoprostanes (IPs), are a useful biomarker for lipid peroxidation. Aim was to assess the association between early peri-postnatal IPs, white matter injury (WMI) at term equivalent age (TEA), and neurodevelopmental outcome in preterm infants.
Methods: Infants with a gestational age (GA) below 28 weeks who had an MRI at TEA were included. IPs were measured in cord blood (cb) at birth and on plasma (pl) between 24 and 48 h after birth. WMI was assessed using Woodward MRI scoring system. Multiple regression analyses were performed to assess the association between IPs with WMI and then with BSITD-III scores at 24 months corrected age (CA). Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive value of pl-IPs for the development of WMI.
Results: Forty-four patients were included. cb-IPs were not correlated with WMI score at TEA, whereas higher pl-IPs and lower GA predicted higher WMI score (p = 0.037 and 0.006, respectively) after controlling for GA, FiO2 at sampling and severity of IVH. The area under the curve was 0.72 (CI 95% = 0.51-0.92). The pl-IPs levels plotted curve indicated that 31.8 pg/ml had the best predictive threshold with a sensitivity of 86% and a specificity of 60%, to discriminate newborns with any WMI from newborns without WMI. IPs were not associated with outcome at 24 months.
Conclusion: Early measurement of pl-IPs may help discriminate patients showing abnormal WMI score at TEA, thus representing an early biomarker to identify newborns at risk for brain injury.
Copyright © 2021 Coviello, Perrone, Buonocore, Negro, Longini, Dani, de Vries, Groenendaal, Vijlbrief, Benders and Tataranno.

Entities:  

Keywords:  brain injury; isoprostanes; oxidative stress; preterm infants; white matter injury

Year:  2021        PMID: 33585368      PMCID: PMC7874160          DOI: 10.3389/fped.2020.618622

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  51 in total

1.  Signal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice.

Authors:  Hye-Youn Cho; Daniel L Morgan; Alison K Bauer; Steven R Kleeberger
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

Review 2.  Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.

Authors:  Joseph J Volpe
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

3.  Neonatal MRI to predict neurodevelopmental outcomes in preterm infants.

Authors:  Lianne J Woodward; Peter J Anderson; Nicola C Austin; Kelly Howard; Terrie E Inder
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

4.  Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

Authors:  L J Roberts; T J Montine; W R Markesbery; A R Tapper; P Hardy; S Chemtob; W D Dettbarn; J D Morrow
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  Neurodevelopmental Outcomes in Preterm Infants with White Matter Injury Using a New MRI Classification.

Authors:  Miriam Martinez-Biarge; Floris Groenendaal; Karina J Kersbergen; Manon J N L Benders; Francesca Foti; Ingrid C van Haastert; Frances M Cowan; Linda S de Vries
Journal:  Neonatology       Date:  2019-05-20       Impact factor: 4.035

6.  Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age.

Authors:  Mario Comporti; Cinzia Signorini; Silvia Leoncini; Giuseppe Buonocore; Viviana Rossi; Lucia Ciccoli
Journal:  Free Radic Biol Med       Date:  2004-09-01       Impact factor: 7.376

7.  Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia.

Authors:  Robin L Haynes; Rebecca D Folkerth; Rachael J Keefe; Iyue Sung; Luke I Swzeda; Paul A Rosenberg; Joseph J Volpe; Hannah C Kinney
Journal:  J Neuropathol Exp Neurol       Date:  2003-05       Impact factor: 3.685

8.  Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature.

Authors:  Xin Hou; L Jackson Roberts; Fernand Gobeil; DouglasF Taber; Kazuo Kanai; Daniel Abran; Sonia Brault; Daniella Checchin; Florian Sennlaub; Pierre Lachapelle; DayaR Varma; Sylvain Chemtob
Journal:  Free Radic Biol Med       Date:  2004-01-15       Impact factor: 7.376

9.  New Dutch reference curves for birthweight by gestational age.

Authors:  Gerard H A Visser; Paul H C Eilers; Patty M Elferink-Stinkens; Hans M W M Merkus; Jan M Wit
Journal:  Early Hum Dev       Date:  2009-11-13       Impact factor: 2.079

10.  Brain injury and altered brain growth in preterm infants: predictors and prognosis.

Authors:  Hiroyuki Kidokoro; Peter J Anderson; Lex W Doyle; Lianne J Woodward; Jeffrey J Neil; Terrie E Inder
Journal:  Pediatrics       Date:  2014-08       Impact factor: 7.124

View more
  6 in total

1.  Antioxidant Effect of Melatonin in Preterm Newborns.

Authors:  Lucia Marseglia; Eloisa Gitto; Elisa Laschi; Maurizio Giordano; Carmelo Romeo; Laura Cannavò; Anna Laura Toni; Giuseppe Buonocore; Serafina Perrone
Journal:  Oxid Med Cell Longev       Date:  2021-11-19       Impact factor: 6.543

2.  Isoprostanoid Plasma Levels Are Relevant to Cerebral Adrenoleukodystrophy Disease.

Authors:  Cinzia Signorini; Claudio De Felice; Thierry Durand; Jean-Marie Galano; Camille Oger; Silvia Leoncini; Joussef Hayek; Jetty Chung-Yung Lee; Troy C Lund; Paul J Orchard
Journal:  Life (Basel)       Date:  2022-01-20

3.  Early versus late parenteral nutrition in term and late preterm infants: study protocol for a randomised controlled trial.

Authors:  Kwi Moon; Elizabeth Mckinnon; Kevin Croft; Delia Hendrie; Sanjay Patole; Karen Simmer; Shripada Rao
Journal:  BMC Pediatr       Date:  2022-08-30       Impact factor: 2.567

4.  Pharmacodynamic Effects of Standard versus High Caffeine Doses in the Developing Brain of Neonatal Rats Exposed to Intermittent Hypoxia.

Authors:  Kutilda Soontarapornchai; Charles L Cai; Taimur Ahmad; Jacob V Aranda; Ivan Hand; Kay D Beharry
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

Review 5.  Free Radicals and Neonatal Brain Injury: From Underlying Pathophysiology to Antioxidant Treatment Perspectives.

Authors:  Silvia Martini; Laura Castellini; Roberta Parladori; Vittoria Paoletti; Arianna Aceti; Luigi Corvaglia
Journal:  Antioxidants (Basel)       Date:  2021-12-18

Review 6.  Neonatal diseases and oxidative stress in premature infants: an integrative review.

Authors:  Versiéri Oliveira de Almeida; Renan Augusto Pereira; Sérgio Luís Amantéa; Cláudia Ramos Rhoden; Maurício Obal Colvero
Journal:  J Pediatr (Rio J)       Date:  2021-12-23       Impact factor: 2.990

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.